CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Equal Entertainment LLC.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
We need your help
Your support makes The Advocate's original LGBTQ+ reporting possible. Become a member today to help us continue this work.
Your support makes The Advocate's original LGBTQ+ reporting possible. Become a member today to help us continue this work.
Low demand is prompting drugmaker Roche to discontinue two of its anti-HIV drugs, AIDSmap.com reports. The company will stop production of its nucleoside reverse transcriptase inhibitor Hivid, also known as ddC, and its protease inhibitor Fortovase. Hivid is rarely prescribed by physicians because studies have shown it can cause peripheral neuropathy in as many as 31% of the HIV patients taking it. Roche's protease inhibitor Fortovase is not as well-tolerated as its other protease drug, Invirase, say company officials. The drugs will be discontinued in 2006 or shortly thereafter.
From our Sponsors
Most Popular
Watch Now: Pride Today
Latest Stories
Trump's DOJ subpoenas doctors and medical clinics that care for transgender youth
July 11 2025 9:36 AM
True
After trans people, Trump now erases bisexual people from Stonewall National Monument
July 10 2025 10:45 PM
Black trans woman Dream Johnson killed in Washington, D.C.
July 10 2025 7:59 PM
5 lesbian power couples who play for the same sports team
July 10 2025 12:13 PM